Picture of DNA strand

Pioneering chemical biology & medicinal chemistry through Open Access research...

Strathprints makes available scholarly Open Access content by researchers in the Department of Pure & Applied Chemistry, based within the Faculty of Science.

Research here spans a wide range of topics from analytical chemistry to materials science, and from biological chemistry to theoretical chemistry. The specific work in chemical biology and medicinal chemistry, as an example, encompasses pioneering techniques in synthesis, bioinformatics, nucleic acid chemistry, amino acid chemistry, heterocyclic chemistry, biophysical chemistry and NMR spectroscopy.

Explore the Open Access research of the Department of Pure & Applied Chemistry. Or explore all of Strathclyde's Open Access research...

Rapid internationalization and sustained competitive advantage in US and UK life science international new ventures: a resource based view

Warner, Karl and Carrick, Jon (2011) Rapid internationalization and sustained competitive advantage in US and UK life science international new ventures: a resource based view. In: International Entrepreneurship in the Life Sciences. Edward Elgar Publishing Ltd, Cheltenham, UK, pp. 175-193. ISBN 978 1 84980 819 4

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

This chapter uses the resource based view (RBV) to study rapid internationalisation and sustained competitive advantage of life science international new ventures (INVs). Applying Hitt et al (2005) RBV framework, we research life science INVs tangible and intangible resources to assess rapid internationalisation and sustained competitive advantage. Cross-national in design, we conduct depth qualitative interviews with US and UK life science INVs to reveal resources that induce sustainable competitive advantage. Our case study findings suggest that the US and UK life science INVs are similar in that they are both rich in intangible resources and this knowledge has facilitated rapid international growth and sustained advantage. However, the results identify that life science funding models inherently differ between the US and UK and the availability of capital impacts on survival, growth and internationalisation. We conclude by offering insights into how these critical resources can be antecedents to building dynamic capabilities that lead to rapid internationalisation and sustained competitive advantage.